日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sensitivity of cognitive function tests to acute hypoxia in healthy subjects: a systematic literature review

健康受试者认知功能测试对急性缺氧的敏感性:系统性文献综述

Post, Titiaan E; Heijn, Laurens G; Jordan, Jens; van Gerven, Joop M A

European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea

欧洲呼吸学会关于非CPAP疗法治疗阻塞性睡眠呼吸暂停的指南

Randerath, Winfried; Verbraecken, Johan; de Raaff, Christel A L; Hedner, Jan; Herkenrath, Simon; Hohenhorst, Winfried; Jakob, Tina; Marrone, Oreste; Marklund, Marie; McNicholas, Walter T; Morgan, Rebecca L; Pepin, Jean-Louis; Schiza, Sofia; Skoetz, Nicole; Smyth, Dan; Steier, Jörg; Tonia, Thomy; Trzepizur, Wojciech; van Mechelen, Piet-Heijn; Wijkstra, Peter

Potent interaction of flavopiridol with MRP1

黄酮吡啶醇与MRP1的强效相互作用

Hooijberg, J H; Broxterman, H J; Scheffer, G L; Vrasdonk, C; Heijn, M; de Jong, M C; Scheper, R J; Lankelma, J; Pinedo, H M

Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb

CD3 mAb 在全血细胞培养中诱导 CD8bright+ 细胞上白细胞介素-2 受体表达的能力较差。这对 CD3 mAb 免疫疗法具有重要意义。

Janssen, R A; Heijn, A A; The, T H; de Leij, L

HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients

在肾细胞癌患者接受皮下重组白细胞介素-2治疗期间,表达HLA-Dr的CD8bright细胞仅暂时存在于循环系统中。

Janssen, R A; Buter, J; Straatsma, E; Heijn, A A; Sleijfer, D T; de Vries, E G; Mulder, N H; The, T H; de Leij, L